Prognostic Factors and Survival Outcomes of Patients With Early HER2+ Breast Cancer Treated With Trastuzumab in a Brazilian Public Reference Center: A Real-World Study
-
Published:2023-12
Issue:8
Volume:23
Page:864-875.e7
-
ISSN:1526-8209
-
Container-title:Clinical Breast Cancer
-
language:en
-
Short-container-title:Clinical Breast Cancer
Author:
Mattar AndréORCID,
Hegg Roberto,
Tayar Daiane O.ORCID,
Rocha Mauricio,
Terzian Ana Luisa. B.,
Oliveira Renato W.,
Julian Guilherme S.ORCID,
Gebrim Luiz H.
Subject
Cancer Research,Oncology